What does CUSIP 36118A100 represent in this 13F holders report?

CUSIP 36118A100 is the security identifier for FUSN - FUSION PHARMACEUTICALS INC - COM used to aggregate holder disclosures.

How many institutions held FUSN - FUSION PHARMACEUTICALS INC - COM in Q1 2021?

37 institutional investors reported FUSN - FUSION PHARMACEUTICALS INC - COM for Q1 2021. Use the holders table for investor-level position and value details.

FUSION PHARMACEUTICALS INC - COM (FUSN)

CUSIP: 36118A100

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class: Equity / COM
Total 13F shares: 27,602,138
Share change: +372,790
Total reported value: $295,864,322
Price per share: $10.72
Number of holders: 37
Value change: +$3,312,121
Number of buys: 15
Number of sells: 13

Quarterly Holders Quick Answers

What is CUSIP 36118A100?
CUSIP 36118A100 identifies FUSN - FUSION PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2021
Previous quarter: Q4 2020

Recent filing periods for CUSIP 36118A100:

Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022

Institutional Holders of FUSION PHARMACEUTICALS INC - COM (FUSN) as of Q1 2021

As of 31 Mar 2021, FUSION PHARMACEUTICALS INC - COM (FUSN) was held by 37 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 27,602,138 shares. The largest 10 holders included Johnson & Johnson Innovation - JJDC, Inc., ORBIMED ADVISORS LLC, FMR LLC, CANADA PENSION PLAN INVESTMENT BOARD, ADAMS STREET PARTNERS LLC, TPG Group Holdings (SBS) Advisors, Inc., PERCEPTIVE ADVISORS LLC, Pivotal bioVenture Partners Investment Advisor LLC, Rock Springs Capital Management LP, and BlackRock Inc.. This page lists 37 institutional shareholders reporting positions in this security for the Q1 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.